EG Private Equity invests globally in companies with a high added value potential. Although the firm concentrates on financial investments, it also provides independent, expert advice on management, marketing and strategy as required with a view to strengthening competitive advantages and enhancing operational and financial performance.
What we inveﬆ in
- Venture Capital and Private Equity projects
- Pre-IPO and pre-M&A investment rounds
- Small and mid-cap companies ($100 million- $ 2 billion)
- Most promising industries (Fintech, Marketplaces, Biotech, SaaS and Big Data)
- Projected IRR: > 30%
- Cash-on-cash: > 2x
- Investment period: up to 3 years
- EG Private Equity partners with leading global PE and VC funds and Investment banks on direct investments, co-investments, fund participation and secondary opportunities. This allows our clients to invest in various asset classes according to agreed investment objectives and criteria.
Selected portfolio companies
Pathway Genomics has developed a genetic testing platform which includes numerous diagnostic tests for genetic biomarkers to address a range of pervasive healthcare needs. Their key products are tests, identifying risk of inherited and heart diseases, cancer and genetic variations with an impact on body’s sensation along with genetic analysis methods and weight control.
IHS is a leading telecom towers company that owns and manages telecommunication towers in five Sub-Saharan Africa countries: Republic of Côte d’Ivoire, Nigeria, Republic of Rwanda, Zambia and Cameroon.
Prosper is the second largest US marketplace for peer-to-peer («P2P») consumer lending. Prosper directly connects lenders with borrowers, thus significantly decreasing loan interest rates for borrowers and increasing yields for investors by eliminating the majority of costs traditional banks incur.
Palantir Technologies develops applications and platforms for the integration, visualisation and analysis of a large quantities of data. These platforms help clients analyse trends and gain valuable insights from silos of data.
Blue Apron is a grocery delivery service company that delivers a recipes and the required ingredients to customer’s home.
Numecent is a developer of a cloud paging technology, transmitting pre-virtualized native software that allows a customer to run application 20-100 times faster using only 6.5% of its total size. Company’s clients include Amazon Web Services, Novartis, ICAP and others.
Dianrong is a Chinese peer-to-peer lending company that specialises in small consumer and business loans. Among investors include Jack Ma (Alibaba), Tiger Global, Standard Chartered Bank, Sun Hung Kai and others.
RetroSense Therapeutics is a biotechnology company developing a game-changing gene therapy to restore vision for patients suffering from blindness due to retinitis pigmentosa (RP) and advanced dry age-related macular degeneration (advanced dry-AMD).
StoreDot is a leader in innovation for materials and their device applications, developing ground-breaking technologies based on a unique methodology for the design, synthesis and tuning of new organic compounds. Investors include Millhouse, Samsung Ventures, Singulariteam.
Fundry provides funds to small and medium enterprises in exchange for a percentage of the daily business income. This structure allows merchant cash advance companies to fluctuate in line with the merchants sales volumes thereby giving merchants greater flexibility.
ADC Therapeutics develops antibody drug conjugates and non-antibody drug conjugate products. The company has licenses for twenty plus molecules that were developed on its own platform. ADC maintains several partnerships with leading companies on medical market such as AstraZeneca, Cancer Research UK and Genmab.
CloudEndure provides services in cloud migration and disaster recovery (DR) for large and small enterprises.